
Find a Doctor

Robert Yoo, DO, is a medical oncologist and an assistant professor in the Department of Neurology at Barrow Neurological Institute. He is board certified in medical oncology and hematology by the American Osteopathic Board of Internal Medicine.
Dr. Yoo’s expertise includes caring for patients with aggressive primary brain tumors, such as glioblastoma, and tumors that have metastasized to the brain or spine. With his hematology background, Dr. Yoo also treats blood cancer types involving the brain and spine, such as lymphoma or multiple myeloma. He is a member of the American Osteopathic Association, the American Society of Clinical Oncology, the American Society of Hematology, and the Society for Neuro-Oncology.
Dr. Yoo earned his medical degree from the Michigan State University College of Osteopathic Medicine in East Lansing. He completed his internal medicine residency at Beaumont Hospital in Farmington Hills, the primary teaching hospital of Michigan State University. He also completed a fellowship in hematology and oncology at the Barbara Ann Karmanos Cancer Institute, an affiliate of the Wayne State University School of Medicine in Detroit.
Dr. Yoo has a longstanding interest in genomics and tumors with unique molecular biology. He believes that a better understanding of tumor biology can help overcome treatment resistance to provide precision-based treatments for brain tumors. Dr. Yoo emphasizes comprehensive, state-of-the-art patient care with treatment options such as immunotherapy, targeted therapy agents, and cancer vaccines.
- Fellowship, Chief Fellow, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Hematology/Oncology, 2015-2018.
- Residency, Beaumont Hospital, Michigan State University, Internal Medicine, 2012-2015
- DO, Michigan State University College of Osteopathic Medicine, 2012
- BS, Michigan State University, Human Biology, 2007
- American Osteopathic Association
- American Society of Clinical Oncology
- American Society of Hematology
- Society for Neuro-Oncology
- 40-Under-40 Business Leadership Award, Phoenix Business Journal, 2020
A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
Date: 01/2022
Authors: Shwetal Mehta, Roberto Fiorelli, Xun Bao, Chelsea Pennington-Krygier, Alanna Derogatis, Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai
Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries
Date: 01/2021
Authors: Alexis Koskan, Lynne Klasko-Foster, Chad Stecher, Sue Rodriguez, Deborah Helitzer, Wonsuk Yoo
American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version
Date: 01/2021
Authors: Lawrence J. Hirsch, Michael W.K. Fong, Markus Leitinger, Suzette M. LaRoche, Sandor Beniczky, Nicholas S. Abend, N. S. Abend, Jong Woo Lee, Courtney J. Wusthoff, Cecil D. Hahn, M. Brandon Westover, Elizabeth E. Gerard, Susan T. Herman, Hiba Arif Haider, Gamaleldin Osman, Andres Rodriguez-Ruiz, Carolina B. Maciel, Emily J. Gilmore, Andres Fernandez, Eric S. Rosenthal, Jan Claassen, Aatif M. Husain, Ji Yeoun Yoo, Elson L. So, Peter W. Kaplan, Marc R. Nuwer, Michel van Putten, Raoul Sutter, Frank W. Drislane, Eugen Trinka, Nicolas Gaspard
TMEM100 is a key factor for specification of lymphatic endothelial progenitors
Date: 08/2020
Authors: Eun Hye Moon, Yong Hwan Kim, Phuong Nhung Vu, Hyunjin Yoo, Kwonho Hong, Young Jae Lee, S. Paul Oh
Patterns and disparities in human papillomavirus (HPV) vaccine uptake for young female adolescents among U.S. States: NIS-teen (2008–2016)
Date: 07/2020
Authors: Wonsuk Yoo, Alexis Koskan, Matthew Scotch, Heidi Pottinger, Warner K. Huh, Deborah Helitzer
- English

- (602) 406-6387
- Fax: (602) 406-2931

Robert Yoo, DO, is a medical oncologist and an assistant professor in the Department of Neurology at Barrow Neurological Institute. He is board certified in medical oncology and hematology by the American Osteopathic Board of Internal Medicine.
Dr. Yoo’s expertise includes caring for patients with aggressive primary brain tumors, such as glioblastoma, and tumors that have metastasized to the brain or spine. With his hematology background, Dr. Yoo also treats blood cancer types involving the brain and spine, such as lymphoma or multiple myeloma. He is a member of the American Osteopathic Association, the American Society of Clinical Oncology, the American Society of Hematology, and the Society for Neuro-Oncology.
Dr. Yoo earned his medical degree from the Michigan State University College of Osteopathic Medicine in East Lansing. He completed his internal medicine residency at Beaumont Hospital in Farmington Hills, the primary teaching hospital of Michigan State University. He also completed a fellowship in hematology and oncology at the Barbara Ann Karmanos Cancer Institute, an affiliate of the Wayne State University School of Medicine in Detroit.
Dr. Yoo has a longstanding interest in genomics and tumors with unique molecular biology. He believes that a better understanding of tumor biology can help overcome treatment resistance to provide precision-based treatments for brain tumors. Dr. Yoo emphasizes comprehensive, state-of-the-art patient care with treatment options such as immunotherapy, targeted therapy agents, and cancer vaccines.

- (602) 406-6387
- Fax: (602) 406-2931
- Fellowship, Chief Fellow, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Hematology/Oncology, 2015-2018.
- Residency, Beaumont Hospital, Michigan State University, Internal Medicine, 2012-2015
- DO, Michigan State University College of Osteopathic Medicine, 2012
- BS, Michigan State University, Human Biology, 2007
- American Osteopathic Association
- American Society of Clinical Oncology
- American Society of Hematology
- Society for Neuro-Oncology
- 40-Under-40 Business Leadership Award, Phoenix Business Journal, 2020
A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
Date: 01/2022
Authors: Shwetal Mehta, Roberto Fiorelli, Xun Bao, Chelsea Pennington-Krygier, Alanna Derogatis, Seongho Kim, Wonsuk Yoo, Jing Li, Nader Sanai
Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries
Date: 01/2021
Authors: Alexis Koskan, Lynne Klasko-Foster, Chad Stecher, Sue Rodriguez, Deborah Helitzer, Wonsuk Yoo
American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version
Date: 01/2021
Authors: Lawrence J. Hirsch, Michael W.K. Fong, Markus Leitinger, Suzette M. LaRoche, Sandor Beniczky, Nicholas S. Abend, N. S. Abend, Jong Woo Lee, Courtney J. Wusthoff, Cecil D. Hahn, M. Brandon Westover, Elizabeth E. Gerard, Susan T. Herman, Hiba Arif Haider, Gamaleldin Osman, Andres Rodriguez-Ruiz, Carolina B. Maciel, Emily J. Gilmore, Andres Fernandez, Eric S. Rosenthal, Jan Claassen, Aatif M. Husain, Ji Yeoun Yoo, Elson L. So, Peter W. Kaplan, Marc R. Nuwer, Michel van Putten, Raoul Sutter, Frank W. Drislane, Eugen Trinka, Nicolas Gaspard
TMEM100 is a key factor for specification of lymphatic endothelial progenitors
Date: 08/2020
Authors: Eun Hye Moon, Yong Hwan Kim, Phuong Nhung Vu, Hyunjin Yoo, Kwonho Hong, Young Jae Lee, S. Paul Oh
Patterns and disparities in human papillomavirus (HPV) vaccine uptake for young female adolescents among U.S. States: NIS-teen (2008–2016)
Date: 07/2020
Authors: Wonsuk Yoo, Alexis Koskan, Matthew Scotch, Heidi Pottinger, Warner K. Huh, Deborah Helitzer
- English